Single/JJ
strand/NN
conformation/NN
polymorphism/NN
analysis/NN
of/IN
androgen/NN
receptor/NN
gene/NN
mutations/NNS
in/IN
patients/NNS
with/IN
androgen/NN
insensitivity/NN
syndromes/NNS
:/:
application/NN
for/IN
diagnosis/NN
,/,
genetic/JJ
counseling/NN
,/,
and/CC
therapy/NN
./.

Recent/JJ
studies/NNS
indicate/VBP
that/IN
mutations/NNS
in/IN
the/DT
androgen/NN
receptor/NN
gene/NN
are/VBP
associated/VBN
with/IN
androgen/NN
insensitivity/NN
syndromes/NNS
,/,
a/DT
heterogeneous/JJ
group/NN
of/IN
related/JJ
disorders/NNS
involving/VBG
defective/JJ
sexual/JJ
differentiation/NN
in/IN
karyotypic/JJ
males/NNS
./.
=====
In/IN
this/DT
report/NN
,/,
we/PRP
address/VBP
the/DT
possibility/NN
of/IN
rapid/JJ
mutational/JJ
analysis/NN
of/IN
the/DT
androgen/NN
receptor/NN
gene/NN
for/IN
initial/JJ
diagnosis/NN
,/,
genetic/JJ
counseling/NN
,/,
and/CC
molecular/JJ
subclassification/NN
of/IN
affected/VBN
patients/NNS
and/CC
their/PRP$
families/NNS
./.
=====
DNA/NN
from/IN
peripheral/JJ
blood/NN
leukocytes/NNS
of/IN
six/CD
patients/NNS
from/IN
five/CD
families/NNS
with/IN
various/JJ
degrees/NNS
of/IN
androgen/NN
insensitivity/NN
was/VBD
studied/VBN
./.
=====
Exons/NNS
2/CD
to/TO
8/CD
of/IN
the/DT
androgen/NN
receptor/NN
gene/NN
were/VBD
analyzed/VBN
using/VBG
a/DT
combination/NN
of/IN
single/JJ
strand/NN
conformation/NN
polymorphism/NN
analysis/NN
and/CC
direct/JJ
DNA/NN
sequencing/NN
./.
=====
Female/JJ
family/NN
members/NNS
were/VBD
also/RB
studied/VBN
to/TO
identify/VB
heterozygote/NN
carriers/NNS
./.
=====
Point/NN
mutations/NNS
in/IN
the/DT
AR/NN
gene/NN
were/VBD
identified/VBN
in/IN
all/DT
six/CD
patients/NNS
,/,
and/CC
all/DT
mutations/NNS
caused/VBD
amino/NN
acid/NN
substitutions/NNS
./.
=====
One/CD
patient/NN
with/IN
incomplete/JJ
androgen/NN
insensitivity/NN
was/VBD
a/DT
mosaic/NN
for/IN
the/DT
mutation/NN
./.
=====
Four/CD
of/IN
the/DT
five/CD
mothers/NNS
,/,
as/RB
well/RB
as/IN
a/DT
young/JJ
sister/NN
of/IN
one/CD
patient/NN
,/,
were/VBD
carriers/NNS
of/IN
the/DT
mutation/NN
present/JJ
in/IN
the/DT
affected/VBN
child/NN
./.
=====
Our/PRP$
data/NNS
show/VBP
that/IN
new/JJ
mutations/NNS
may/MD
occur/VB
in/IN
the/DT
androgen/NN
receptor/NN
gene/NN
leading/VBG
to/TO
sporadic/JJ
androgen/NN
insensitivity/NN
syndrome/NN
./.
=====
Molecular/JJ
genetic/JJ
characterization/NN
of/IN
the/DT
variant/JJ
allele/NN
can/MD
serve/VB
as/IN
a/DT
primary/JJ
tool/NN
for/IN
diagnosis/NN
and/CC
subsequent/JJ
therapy/NN
,/,
and/CC
can/MD
provide/VB
a/DT
basis/NN
for/IN
distinguishing/VBG
heterozygous/JJ
carriers/NNS
in/IN
familial/JJ
androgen/NN
resistance/NN
./.
=====
The/DT
identification/NN
of/IN
carriers/NNS
is/VBZ
of/IN
substantial/JJ
clinical/JJ
importance/NN
for/IN
genetic/JJ
counseling/NN
./.